ESRD is rare; its treatment with dialysis or transplantation is very costly. Interventions to lessen morbidity and cost of care after beginning of dialysis are extremely optional. Drug-related problems (DRPs) are a main source of hospital admissions. One study stated 28% of hospital admissions being due to drug-related problems. Insufficient patient history information is the next leading cause of stated error with 24% of error being accredited to lack of information about the patient. Identification and resolution of DRPs can ensue through delivery of pharmaceutical care. Establishment of clinical pharmacy service/pharmaceutical care to dialysis patients is a cost-effective way to identify, resolve and avoid DRPs. Medication reviews for dialysis patients are composite to accomplish due to multiple medications, multiple indications, frequent dose changes, multiple health care providers and patient adherence concerns. Preceding research has confirmed that multidisciplinary clinics in chronic disease management increase patient outcomes. Establishment of such a service in the outpatient hospital setting overwhelms the issues concerning to pharmacists’ access to patients medical and laboratory data, however additional prescribing for clinical pharmacists working in the hospital outpatient clinics would save the choice of this pharmacists’ role for the future.
Loading....